Abrezekimab
Modify Date: 2025-10-25 11:04:12
Abrezekimab structure
|
Common Name | Abrezekimab | ||
|---|---|---|---|---|
| CAS Number | 2043952-59-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AbrezekimabAbrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma[1]. |
| Name | Abrezekimab |
|---|
| Description | Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma[1]. |
|---|---|
| Related Catalog | |
| Target |
IL-13 |
| References |
| No Any Chemical & Physical Properties |